Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
The average number of authors listed per publication has increased significantly in major radiology journals, according to a recent study published by Academic Radiology.
Dr. du Plessis of the Salford Royal NHS Foundation Trust discusses how wider digital adoption will speed up reporting, provide greater intelligence, join-up care and allow pathologists to carry out their work much more efficiently.
Gotham published an interview this week with Eva Andersson-Dubin, MD, and Elisa Port, MD, of the Dubin Breast Center of the Tisch Cancer Institute at Mount Sinai Medical Center in New York, N.Y.
iCAD, Inc. (Nasdaq: ICAD) announced today that it will feature its latest solutions for advanced image analysis and workflow tools for the early identification of cancer at the Radiological Society of North American (RSNA) 2015 Annual Meeting in Chicago from November 29 to December 4, 2015.
There are few topics in healthcare generally or medical imaging specifically that garner headlines like breast imaging. There will, of course, be plenty of sessions covering the topic at RSNA 2015, and here are a few that caught the attention of our editorial team.
Mallinckrodt plc (NYSE: MNK), a leading specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared INOmax DSIR® Plus MRI device for delivery of INOMAX® (nitric oxide) for inhalation during MRI procedures.
Carestream Health’s new CARESTREAM DRX Plus 3543 and DRX Plus 3543C detectors are now shipping to healthcare providers in countries across the globe.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
